Man Group
HSTO

Man Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Man Group’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-131
Closed -$152K – 2188
2018
Q3 		$152K Buy
131
+5
+4% +$4.61K ﹤0.01% 2038
2018
Q2 		$108K Buy
+126
New +$105K ﹤0.01% 2067

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Man Group's HSTO Position: Q4 2018 in Review

Man Group sold out of Histogen Inc. Common Stock (HSTO) in Q4 2018, closing a stake of 131 shares — an estimated $152K sold.

Man Group first reported a position in HSTO in Q2 2018 and held it in 2 quarters. The position peaked at $152K in Q3 2018. 52 funds tracked by Wall St. Rank hold HSTO as of Q4 2018.

  • Man Group reported no remaining Histogen Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Man Group sold 131 Histogen Inc. Common Stock shares in Q4 2018, an estimated $152K.
  • Man Group first reported a position in Histogen Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • Man Group's Histogen Inc. Common Stock position peaked at $152K in Q3 2018.
  • 52 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2018.

Based on Man Group's 13F filing for Q4 2018, filed 14 Feb 2019.